Abstract
Previously undescribed ocular and dermatologic complications of prolonged chlorpromazine therapy have been noted in 70 patients of a series of many thousands receiving similar therapy. All affected patients were women who had been receiving high doses of chlorpromazine, averaging 500 to 1500 mg. daily, for at least three to five years before the complications became apparent. Skin manifestations consisted of a peculiar purplish pigmentation of the skin of exposed areas of the face, neck and hands, characterized histologically by deposition of material with the staining properties of melanin in the superficial layers of the dermis, particularly in a perivascular distribution. Ocular complications consisted of granular opacity of the cornea and often of the lens as well, the latter producing a central stellate type of cataract.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BERNSTEIN C., KLOTZ S. D. Allergenicity of tranquilizing drugs. J Am Med Assoc. 1957 Mar 16;163(11):930–933. doi: 10.1001/jama.1957.02970460020006. [DOI] [PubMed] [Google Scholar]
- GREAVES D. P. Symposium on metabolic diseases of the eye. Galactosemia. Proc R Soc Med. 1963 Jan;56:24–25. [PubMed] [Google Scholar]
- JOHNSON W. Toxic amblyopia from perphenazine (fentazin). J Ment Sci. 1960 Jan;106:352–354. doi: 10.1192/bjp.106.442.352. [DOI] [PubMed] [Google Scholar]
- ROIZIN L., TRUE C., KNIGHT M. Structural effects of tranquilizers. Res Publ Assoc Res Nerv Ment Dis. 1959;37:285–324. [PubMed] [Google Scholar]
- SWANSON D. W. Six months observation of psychotic identical twins. Am J Psychiatry. 1961 Aug;118:166–168. doi: 10.1176/ajp.118.2.166. [DOI] [PubMed] [Google Scholar]
- WINKELMAN N. W., Jr An appraisal of chlorpromazine; general principles for administration of chlorpromazine, based on experience with 1,090 patients. Am J Psychiatry. 1957 May;113(11):961–971. doi: 10.1176/ajp.113.11.961. [DOI] [PubMed] [Google Scholar]